Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Cognition in Early Phase Schizophrenia
NCT02008773Phase 2Completed
- Sponsor
- Indiana University
- Start
- Mar 2014
- Primary completion
- Jun 2017
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in schizophrenia, sponsored by Indiana University. Started Mar 2014; status: completed.
02
Drugs
valaciclovir
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02008773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02008773.